JCAD | The Journal of Clinical and Aesthetic Dermatology (JCAD)

JCAD | The Journal of Clinical and Aesthetic Dermatology

   

JCAD » 04-2009 (April 2009)

Archives

Sponsors

<img src="http://www.jcadonline.com/ad-content/cloderm/banner_noflash.png" >

Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses

April 2009

James Q. Del Rosso, DO, FAOCD; Valley Hospital Medical Center, Las Vegas, Nevada

Howard Sofen, MD; Dermatology Associates, Los Angeles, California;

Barry Leshin, MD; The Skin Surgery Center, Winston-Salem, North Carolina

TC Meng, MD; James Kulp, BS and Sharon Levy, MD, Graceway Pharmaceuticals, Bristol, Tennessee Read the rest of this article »

Posted in 04-2009 (April 2009), Actinic Keratoses, Original Research | No Comments »

Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?

April 2009

Jason J. Emer, MD; The Mount Sinai School of Medicine, Department of Dermatology, New York, New York Read the rest of this article »

Posted in 04-2009 (April 2009), Anti-tumor Necrosis Factor, Literature Review | No Comments »

Reduction in Procedure-associated Pain by Treatment with a Unique Topical Anesthetic Foam Containing 4% Lidocaine

April 2009

Ellen Frankel, MD,St. Joseph’s Hospital, Providence, Rhode Island

Mark W. Trumbore, PhD, Collegium Pharmaceutical, Cumberland, Rhode Island

Disclosure: Dr. Frankel has received research support from Onset Therapeutics. Dr. Trumbore is employed by Collegium Pharmaceutical. Read the rest of this article »

Posted in 04-2009 (April 2009), Original Research | No Comments »

Self-diagnosis of Mild-to-Moderate Acne for Self Treatment with Blue Light Therapy

April 2009

Michael H. Gold, MD, Tennessee Clinical Research Center, Nashville, Tennessee;

Anneke Andriessen; RBC Consultants, The Netherlands

Julie Biron, Tennessee Clinical Research Center, Nashville, Tennessee;

Disclosure: Dr. Gold is a consultant to, performs research for, speaks for, and receives honoraria from Pharos Life; Ms. Andriessen and Ms. Biron report no relevant conflicts of interest. Read the rest of this article »

Posted in 04-2009 (April 2009), Blue Light Therapy, General, Original Research | No Comments »

Use of Oral Doxycycline for Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections

April 2009

James Q. Del Rosso, DO, FAOCD;
Sanjay Bhambri, DO;
Grace Kim, DO

Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada, Touro University College of Osteopathic Medicine, Henderson, Nevada; Clinical Associate Professor, Dermatology, University of Nevada School of Medicine, Las Vegas, Nevada; Las Vegas Skin & Cancer Clinics, Las Vegas and Henderson, Nevada. Dr. Bhambri is Chief Dermatology Resident, Valley Hospital Medical Center, Las Vegas, Nevada. Dr. Kim is a dermatologist at Valley Hospital Medical Center, Las Vegas, Nevada. The authors report no conflicts of interest in relationship to the content of this article. Read the rest of this article »

Posted in 04-2009 (April 2009), Doxycycline Therapy, Questions-Challenges-Controversies | No Comments »